The Japanese Ministry of Health, Labor, and Welfare (MHLW) has granted marketing authorization for Xenpozyme® (olipudase alfa) for the treatment of adult and pediatric...
Visby Medical™, a leading medical diagnostic company, announced that it has received an additional $25.5M in federal funding to develop and validate an at-home...
UCB, a global biopharmaceutical company, on Monday announced that FINTEPLA (fenfluramine) oral solution CIV has been approved in the United States, by the U.S....
Innovent Biologics, Inc., a biopharmaceutical company that develops, manufactures and commercializes medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, and...
Plastikon Healthcare, LLC is voluntarily recalling three (3) lots of Milk of Magnesia 2400 mg/30 mL Oral Suspension, one (1) lot of Acetaminophen 650mg/...